Secretariat opens comment period on draft report reviewing specific exemption for PFOI use to produce PFOB for pharmaceuticals

The Stockholm Convention Secretariat opened an invitation for Parties/observers to submit comments on a draft report reviewing the specific exemption for the use of perfluorooctyl iodide (PFOI) to produce perfluorooctyl bromide (PFOB) for pharmaceutical products. This is a POPs Convention process step that may affect continuation, modification, or expiration of the exemption and therefore future availability of this exemption pathway for regulated entities and supply chains.